ALMR - Company ID 0002104204
The table below shows Alamar Biosciences, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Cash & equivalents | $121.53M | $132.97M | $64.59M |
| Short-term investments | $105.05M | $117.08M | $0.00 |
| Receivables | $21.61M | $20.34M | $19.52M |
| Inventory | $54.13M | $45.41M | $39.93M |
| Total current assets | $317.69M | $331.38M | $141.47M |
| Property, plant & equipment | $15.24M | $13.36M | $10.47M |
| Goodwill | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total assets |
| $378.03M |
| $390.98M |
| $186.45M |
| Accounts payable | $16.55M | $13.79M | $5.63M |
| Total current liabilities | $33.48M | $27.96M | $24.05M |
| Long-term debt | - | - | - |
| Total liabilities | $74.32M | $78.12M | $129.53M |
| Retained earnings | -$216.64M | -$203.30M | -$190.10M |
| Total equity | $303.70M | $312.86M | -$178.07M |